Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG

Approval Number

SIN15817P

Drug Name

PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG

Product Name

PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG

Approval Date

September 23, 2019

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Regulatory Information

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

PARENTERAL

Medical Information

ATC Code

L01BA04

ATC Item Name

pemetrexed

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS PHARMA PTE. LTD.

Manufacturers

DR.REDDY'S LABORATORIES LTD

Active Ingredients

Ingredient Name

Pemetrexed disodium(Amorphous) 551.4 mg eqv to Pemetrexed

Strength

500 mg

Drug MonographPemetrexed

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

PODOXRED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG - HSA Approval | MedPath